Non-opioid Pain Patch Market Share

Statistics for the 2023 & 2024 Non-opioid Pain Patch market share, created by Mordor Intelligence™ Industry Reports. Non-opioid Pain Patch share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Non-opioid Pain Patch Industry

The market is highly fragmented because numerous companies are working to help a large global population suffering from chronic pain. Various market players use different technologies to develop products that facilitate effective and prolonged drug release to increase consumer base and product penetration. Furthermore, the market is highly competitive, with fierce competition between existing players and new entrants. The global non-opioid pain patch market players are Endo Pharmaceuticals, Hisamitsu Pharmaceutical, Sanofi, Sorrento Therapeutics (SCILEX Pharmaceuticals), and TEH SENG Pharmaceutical Mfg. Co., Ltd, Teikoku Seiyaku Co. Ltd, Teva Pharmaceuticals, and Veridian Healthcare.

Non-opioid Pain Patch Market Leaders

  1. Endo Pharmaceuticals Inc.

  2. Hisamitsu Pharmaceutical Co. Inc.

  3. Teva Pharmaceuticals Industries Ltd.

  4. Veridian Healthcare

  5. Sanofi

*Disclaimer: Major Players sorted in no particular order

Non-opioid Pain Patch Market Concentration

Non-opioid Pain Patch Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)